Albany Molecular Research, Inc., provides scientific services, technologies and products. The Company's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing, and a separate, stand-alone research and development division consisting of technology investments, internal drug discovery and niche generic active pharmaceutical ingredient product development. With locations in the United States, Europe and Asia, the Company provides customers with a range of services and cost models. In January 2008, the Company completed the acquisition of FineKem Laboratories Pvt. Limited (FineKem), a manufacturing facility in Aurangabad, India.
(Source: 10-K) – less – More from ZoomInfo »